Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-glucosidase is a hydrolytic enzyme complex found in the brush border of the small intestine, primarily composed of the membrane-bound glycosidases maltase-glucoamylase and sucrase-isomaltase[1][4]. It catalyzes the final step of carbohydrate digestion by cleaving terminal, non-reducing alpha-(1→4)-linked D-glucose residues from dietary disaccharides and oligosaccharides, producing free glucose for absorption[2][6]. These enzymes are essential for proper nutrient acquisition; dysfunction leads to malabsorption syndromes, while inhibition with drugs such as acarbose can therapeutically reduce postprandial hyperglycemia in diabetes mellitus[6]. Mutations in genes encoding these enzymes result in disorders such as congenital sucrase-isomaltase deficiency, leading to gastrointestinal symptoms due to poor carbohydrate digestion[1].
competitive inhibition of alpha-glucosidase activity in the intestinal brush border, delaying carbohydrate breakdown and glucose absorption[6] reduced postprandial blood glucose increases, providing glycemic control in diabetes[6]
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-glucosidase enzyme (intestinal brush border).